fda shortage tirzepatide update Resolves Shortage: Impact on Supply Chain The FDA says the Zepbound

Both the Food and Drug Administration (FDA) and the European Medicines Agency are actively monitoring the psychiatric safety of semaglutide and similar medications after post marketing surveillance reports of depression, suicidal thoughts (ideation), and suicidal behavior in patients taking the drugs for the management of type 2 diabetes or obesity

Tirzepatide, with its established cardiovascular safety profile and completed SURPASS and SURMOUNT programs, provides a more thoroughly characterized risk landscape

It is a synthetic pentapeptide growth hormone secretagogue

[12] El medicamento tambin retrasa el vaciamiento gstrico (un efecto que puede atenuarse con el tiempo), lo que contribuye a una sensacin prolongada de plenitud despus de las comidas